Cite
Gould C, Lickiss J, Kankanige Y, et al. Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target. Br J Haematol. 2021;195(1):113-118doi: 10.1111/bjh.17789.
Gould, C., Lickiss, J., Kankanige, Y., Yerneni, S., Lade, S., Gandhi, M. K., Chin, C., Yannakou, C. K., Villa, D., Slack, G. W., Markham, J. F., Tam, C. S., Nelson, N., Seymour, J. F., Dickinson, M., Neeson, P. J., Westerman, D., & Blombery, P. (2021). Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target. British journal of haematology, 195(1), 113-118. https://doi.org/10.1111/bjh.17789
Gould, Clare, et al. "Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target." British journal of haematology vol. 195,1 (2021): 113-118. doi: https://doi.org/10.1111/bjh.17789
Gould C, Lickiss J, Kankanige Y, Yerneni S, Lade S, Gandhi MK, Chin C, Yannakou CK, Villa D, Slack GW, Markham JF, Tam CS, Nelson N, Seymour JF, Dickinson M, Neeson PJ, Westerman D, Blombery P. Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target. Br J Haematol. 2021 Oct;195(1):113-118. doi: 10.1111/bjh.17789. Epub 2021 Aug 23. PMID: 34426978.
Copy
Download .nbib